Prima is gearing up for a 600 patient clinical trial this is no small task, to put it simply Martin Rogers was not capable (no disrespect) of managing such a task his expertise was in the early stages it was the only move for the company to shake up the board, Mathew Lehman with 10 years heading a CRO through numerous drugs development was the logical move to take the top seat - if you want the best hands in drug development that's where you get it. Who do you think big pharma outsource most of their work to ?
dubai update, page-26
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.005(1.49%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 33.0¢ | $1.220M | 3.642M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57289 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 52306 | 3 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |